|
ZNF317 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.120200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.699390E-01 |
| Normal-vs-Stage2 |
6.614600E-01 |
| Normal-vs-Stage3 |
2.014000E-02 |
| Normal-vs-Stage4 |
3.799500E-02 |
| Stage1-vs-Stage2 |
1.569230E-01 |
| Stage1-vs-Stage3 |
1.382290E-04 |
| Stage1-vs-Stage4 |
7.355200E-04 |
| Stage2-vs-Stage3 |
1.787970E-01 |
| Stage2-vs-Stage4 |
2.018000E-01 |
| Stage3-vs-Stage4 |
8.705400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.226200E-01 |
| Normal-vs-AfricanAmerican |
8.976800E-01 |
| Normal-vs-Asian |
4.635600E-01 |
| Caucasian-vs-AfricanAmerican |
7.964200E-01 |
| Caucasian-vs-Asian |
3.057600E-01 |
| AfricanAmerican-vs-Asian |
4.643600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.316400E-01 |
| Normal-vs-Female |
9.295600E-01 |
| Male-vs-Female |
3.418600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.061400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.049600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.010600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.714300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.121200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.155200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.799600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.849800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.694100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.538010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.994800E-04 |
| Normal-vs-Grade 2 |
3.679200E-01 |
| Normal-vs-Grade 3 |
1.853370E-01 |
| Normal-vs-Grade 4 |
7.362000E-03 |
| Grade 1-vs-Grade 2 |
1.169500E-02 |
| Grade 1-vs-Grade 3 |
9.778800E-04 |
| Grade 1-vs-Grade 4 |
1.812420E-04 |
| Grade 2-vs-Grade 3 |
1.262290E-02 |
| Grade 2-vs-Grade 4 |
2.248600E-04 |
| Grade 3-vs-Grade 4 |
6.307900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.679900E-02 |
| Normal-vs-ccB subtype |
3.342600E-01 |
| ccA subtype-vs-ccB subtype |
5.336100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.914000E-01 |
| Normal-vs-N1 |
3.447800E-01 |
| N0-vs-N1 |
2.889800E-01 |
|
|
